Analyst says sell Abbott after stock 'Overreacted' to COVID-19 opportunity By: TalkMarkets June 01, 2020 at 15:04 PM EDT Goldman says competitors have steadily diminished Abbott's early advantage with their own approvals. Read More >> Related Stocks: Abbott Laboratories Roche Holding AG Basel American Depositary Shares